New Study Shows Predictive Immune Modeling from Cofactor Genomics is Superior to PD-L1 Assays in Predicting Patient Response to Anti-PD-1 Therapy
SCOTTSDALE, Ariz. -- February 27, 2020 -- Cofactor Genomics, the company bridging the precision medicine gap with Predictive Immune Modeling, today announced preliminary results from a collaborative study with Washington University School of Medicine in St. Louis, which demons...
Cofactor Genomics Opens Early Access to New T Cell Exhaustion Models through Predictive Immune Modeling Platform
San Francisco, CA -- November 6, 2019 -- Cofactor Genomics, leaders in RNA-based technologies and diagnostics, announced today they will provide early access to a new feature in their Predictive Immune Modeling platform which enables cell-state characterization within FFPE tis...
Cofactor Genomics Expands Leadership Team and Opens New Boston Predictive Immune Modeling Center
Boston, MA -- September 26, 2019 -- Today Cofactor Genomics announced that it has expanded the leadership team with the promotion of Natalie LaFranzo, PhD to Vice President of Market Development. Dr. LaFranzo’s amplified leadership role includes clinical collaboration manageme...